BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38196348)

  • 1. Optical imaging probes for selective detection of butyrylcholinesterase.
    Dirak M; Chan J; Kolemen S
    J Mater Chem B; 2024 Jan; 12(5):1149-1167. PubMed ID: 38196348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
    Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
    CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
    Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
    Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butyrylcholinesterase in lipid metabolism: A new outlook.
    Gok M; Cicek C; Bodur E
    J Neurochem; 2024 Apr; 168(4):381-385. PubMed ID: 37129444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potent and Selective Acetylcholinesterase/Butyrylcholinesterase Inhibitors by Virtual Screening.
    Xu T; Li S; Li AJ; Zhao J; Sakamuru S; Huang W; Xia M; Huang R
    J Chem Inf Model; 2023 Apr; 63(8):2321-2330. PubMed ID: 37011147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnoses of Pathological States Based on Acetylcholinesterase and Butyrylcholinesterase.
    Pohanka M
    Curr Med Chem; 2020; 27(18):2994-3011. PubMed ID: 30706778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and Computational Analysis Identify Statins as Selective Inhibitors of Human Butyrylcholinesterase.
    Atay MS; Sari S; Bodur E
    Protein J; 2023 Apr; 42(2):104-111. PubMed ID: 36648628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
    Duysen EG; Li B; Darvesh S; Lockridge O
    Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
    Pacheco G; Palacios-Esquivel R; Moss DE
    J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A turn-on fluorescent probe based on ESIPT and AIEE mechanisms for the detection of butyrylcholinesterase activity in living cells and in non-alcoholic fatty liver of zebrafish.
    Pei X; Fang Y; Gu H; Zheng S; Bin X; Wang F; He M; Lu S; Chen X
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Feb; 287(Pt 1):122044. PubMed ID: 36327810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro and in-silico studies of annelated 1,4,7,8-tetrahydroazocine ester derivatives as nanomolar selective inhibitors of human butyrylcholinesterase.
    de Candia M; Titov AA; Viayna A; Kulikova LN; Purgatorio R; Piergiovanni B; Niso M; Catto M; Voskressensky LG; Luque FJ; Altomare CD
    Chem Biol Interact; 2023 Dec; 386():110741. PubMed ID: 37839515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
    Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
    Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholinesterase and butyrylcholinesterase activities in obese Beagle dogs before and after weight loss.
    Tvarijonaviciute A; Ceron JJ; Tecles F
    Vet Clin Pathol; 2013 Jun; 42(2):207-11. PubMed ID: 23550593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease.
    Darvesh S
    Curr Alzheimer Res; 2016; 13(10):1173-7. PubMed ID: 27040140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine inhibits acetylcholinesterase, but not butyrylcholinesterase.
    Pohanka M; Dobes P
    Int J Mol Sci; 2013 May; 14(5):9873-82. PubMed ID: 23698772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of
    Alcorn KN; Oberhauser IA; Politeski MD; Eckroat TJ
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2286935. PubMed ID: 38059272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain.
    Mesulam M; Guillozet A; Shaw P; Quinn B
    Neurobiol Dis; 2002 Feb; 9(1):88-93. PubMed ID: 11848688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of Fmoc-amino esters and amides bearing a substrate like quaternary ammonium group as selective butyrylcholinesterase inhibitors.
    Godinez J; Lee CY; Schwans JP
    Bioorg Med Chem Lett; 2023 Aug; 92():129392. PubMed ID: 37364726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of methoxy-naphthyl linked N-(1-benzylpiperidine) benzamide as a blood-brain permeable dual inhibitor of acetylcholinesterase and butyrylcholinesterase.
    Abdullaha M; Nuthakki VK; Bharate SB
    Eur J Med Chem; 2020 Dec; 207():112761. PubMed ID: 32942070
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.